Rapid Micro Biosystems (RPID) Gross Margin Growth (1y) (2021 - 2026)

Rapid Micro Biosystems (RPID) Gross Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -67.00
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -54.00
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -265.00
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 62.00
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -65.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.00
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 610.00
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -359.00
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 58.00
10 Rapid Micro Biosystems 77.24 Mn 54.29 Mn 371,000.00 -97.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -97.00
Dec 31, 2025 684.00
Sep 30, 2025 746.00
Jun 30, 2025 1,192.00
Mar 31, 2025 -3,592.00
Dec 31, 2024 1,360.00
Sep 30, 2024 1,253.00
Jun 30, 2024 919.00
Mar 31, 2024 1,028.00
Dec 31, 2023 4,440.00
Sep 30, 2023 2,600.00
Jun 30, 2023 2,626.00
Mar 31, 2023 1,432.00
Dec 31, 2022 -2,986.00
Sep 30, 2022 -3,853.00
Jun 30, 2022 -3,933.00
Mar 31, 2022 -3,753.00
Dec 31, 2021 -2,981.00
Sep 30, 2021 -1,682.00
Jun 30, 2021 -326.00